Lars H Lund

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. doi request reprint Association of spironolactone use with all-cause mortality in heart failure: a propensity scored cohort study
    Lars H Lund
    Department of Medicine, Karolinska Institutet, Stockholm, Sweden mail
    Circ Heart Fail 6:174-83. 2013
  2. ncbi request reprint Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fraction
    Lars H Lund
    Department of Medicine, Karolinska Institutet, 17177 Stockholm, Sweden
    Eur Heart J 34:529-39. 2013
  3. doi request reprint Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction
    Lars H Lund
    Department of Medicine, Unit of Cardiology, Karolinska Institutet, Stockholm, Sweden
    JAMA 308:2108-17. 2012
  4. doi request reprint Derived and displayed power consumption, flow, and pulsatility over a range of HeartMate II left ventricular assist device settings
    Lars H Lund
    Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden
    ASAIO J 58:183-90. 2012
  5. pmc Myocardial recovery in peri-partum cardiomyopathy after continuous flow left ventricular assist device
    Lars H Lund
    Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden
    J Cardiothorac Surg 6:150. 2011
  6. doi request reprint Patient selection for left ventricular assist devices
    Lars H Lund
    Department of Cardiology, Section for Heart Failure, Karolinska University Hospital, N305 171 76 Stockholm, Sweden
    Eur J Heart Fail 12:434-43. 2010
  7. ncbi request reprint Peak VO2 in elderly patients with heart failure
    Lars H Lund
    Division of Cardiology and Medicine, Karolinska Institute and Karolinska University Hospital, 171 76 Stockholm, Sweden
    Int J Cardiol 125:166-71. 2008
  8. pmc Ghrelin resistance occurs in severe heart failure and resolves after heart transplantation
    Lars H Lund
    Section for Heart Failure, Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden
    Eur J Heart Fail 11:789-94. 2009
  9. pmc Growth hormone resistance in severe heart failure resolves after cardiac transplantation
    Lars H Lund
    Department of Cardiology, Karolinska University Hospital, N305, Stockholm, Sweden
    Eur J Heart Fail 11:525-8. 2009
  10. ncbi request reprint Triage of patients with moderate to severe heart failure: who should be referred to a heart failure center?
    Tonje Thorvaldsen
    Department of Medicine, Karolinska Institutet, Stockholm, Sweden Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden
    J Am Coll Cardiol 63:661-71. 2014

Collaborators

Detail Information

Publications24

  1. doi request reprint Association of spironolactone use with all-cause mortality in heart failure: a propensity scored cohort study
    Lars H Lund
    Department of Medicine, Karolinska Institutet, Stockholm, Sweden mail
    Circ Heart Fail 6:174-83. 2013
    ..We tested the hypothesis that spironolactone is associated with reduced mortality also in a broad unselected contemporary population with HF and reduced ejection fraction, in particular New York Heart Association (NYHA) I-II...
  2. ncbi request reprint Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fraction
    Lars H Lund
    Department of Medicine, Karolinska Institutet, 17177 Stockholm, Sweden
    Eur Heart J 34:529-39. 2013
    ..The rationale for cardiac resynchronization therapy (CRT) in preserved EF is unknown. The aim was to determine the prevalence of, correlates with, and prognostic impact of QRS prolongation in HF with reduced and preserved EF...
  3. doi request reprint Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction
    Lars H Lund
    Department of Medicine, Unit of Cardiology, Karolinska Institutet, Stockholm, Sweden
    JAMA 308:2108-17. 2012
    ..Three randomized trials of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (ie, renin-angiotensin system [RAS] antagonists) did not reach primary end points but may have had selection bias or been underpowered...
  4. doi request reprint Derived and displayed power consumption, flow, and pulsatility over a range of HeartMate II left ventricular assist device settings
    Lars H Lund
    Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden
    ASAIO J 58:183-90. 2012
    ..These findings have implications for clinicians attempting to optimize settings and assess pump and native heart function...
  5. pmc Myocardial recovery in peri-partum cardiomyopathy after continuous flow left ventricular assist device
    Lars H Lund
    Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden
    J Cardiothorac Surg 6:150. 2011
    ..We describe the clinical course of a patient with severe peri-partum cardiomyopathy (PPCM) rescued with a continuous flow LVAD, who experienced recovery and explantation. We discuss assessment of and criteria for recovery...
  6. doi request reprint Patient selection for left ventricular assist devices
    Lars H Lund
    Department of Cardiology, Section for Heart Failure, Karolinska University Hospital, N305 171 76 Stockholm, Sweden
    Eur J Heart Fail 12:434-43. 2010
    ..This review summarizes recent reports of predictors of poor outcomes and provides an overview of selection for LVAD therapy...
  7. ncbi request reprint Peak VO2 in elderly patients with heart failure
    Lars H Lund
    Division of Cardiology and Medicine, Karolinska Institute and Karolinska University Hospital, 171 76 Stockholm, Sweden
    Int J Cardiol 125:166-71. 2008
    ..This review examines the physiology of aging and the clinical utility of exercise testing in elderly patients with heart failure...
  8. pmc Ghrelin resistance occurs in severe heart failure and resolves after heart transplantation
    Lars H Lund
    Section for Heart Failure, Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden
    Eur J Heart Fail 11:789-94. 2009
    ..Ghrelin is a novel appetite-stimulating hormone. The aim was to determine the role of ghrelin in regulating appetite, food intake, and body composition in HF and post-HTx...
  9. pmc Growth hormone resistance in severe heart failure resolves after cardiac transplantation
    Lars H Lund
    Department of Cardiology, Karolinska University Hospital, N305, Stockholm, Sweden
    Eur J Heart Fail 11:525-8. 2009
    ..Whether GH resistance resolves post HTx is unknown. We aimed to confirm that HF is associated with GH resistance and to test the hypothesis that GH resistance resolves post HTx...
  10. ncbi request reprint Triage of patients with moderate to severe heart failure: who should be referred to a heart failure center?
    Tonje Thorvaldsen
    Department of Medicine, Karolinska Institutet, Stockholm, Sweden Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden
    J Am Coll Cardiol 63:661-71. 2014
    ..The purpose of this study was to evaluate simple criteria for referral of patients from the general practitioner to a heart failure (HF) center...
  11. doi request reprint Peripheral extracorporeal membrane oxygenation as short-term right ventricular support after HeartWare left ventricular assist device implantation
    Magnus Dalén
    Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
    ASAIO J 59:523-5. 2013
    ..We describe the use of peripheral venoarterial extracorporeal membrane oxygenation as a short-term treatment of right heart failure after HeartWare LVAD implantation...
  12. ncbi request reprint Validation of peak exercise oxygen consumption and the Heart Failure Survival Score for serial risk stratification in advanced heart failure
    Lars H Lund
    Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden
    Am J Cardiol 95:734-41. 2005
    ..Peak VO2 and the HFSS can be successfully used for serial evaluation of mortality risk in ambulatory patients who have advanced heart failure...
  13. doi request reprint Association of candesartan vs losartan with all-cause mortality in patients with heart failure
    Maria Eklind-Cervenka
    Department of Cardiology, South Hospital, Stockholm, Sweden
    JAMA 305:175-82. 2011
    ..Different agents have different affinity for the AT(1) receptor and may have different clinical effects, but have not been tested against each other in HF...
  14. doi request reprint Extracorporeal membrane oxygenation as a rescue of intractable ventricular fibrillation and bridge to heart transplantation
    Thomas Fux
    Department of Cardiology, Section for Heart Failure, Karolinska University Hospital, N305, 171 76 Stockholm, Sweden
    Eur J Heart Fail 12:301-4. 2010
    ....
  15. ncbi request reprint Planned repetitive use of levosimendan for heart failure in cardiology and internal medicine in Sweden
    Tonje Thorvaldsen
    Karolinska Institutet, Department of Medicine, Unit of Cardiology, 17177 Stockholm, Sweden Karolinska University Hospital, Department of Cardiology, 17176 Stockholm, Sweden
    Int J Cardiol 175:55-61. 2014
    ..The aim was to assess the use of levosimendan vs. conventional inotropes and the use as planned repetitive vs. acute treatment, in Sweden...
  16. doi request reprint Modifications of skeletal muscle ryanodine receptor type 1 and exercise intolerance in heart failure
    Eric Rullman
    Department of Cardiology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
    J Heart Lung Transplant 32:925-9. 2013
    ..However, it is not known whether similar remodeling of RyR1 in skeletal muscle occurs in patients with heart failure, and if this is associated with impairment of physical activity...
  17. doi request reprint Women have better long-term prognosis than men after cardiac resynchronization therapy
    Stanislava Zabarovskaja
    Section for Heart Failure, Department of Cardiology, Karolinska University Hospital, 17176 Stockholm, Sweden
    Europace 14:1148-55. 2012
    ..However, CRT may be under-utilized in women and data on long-term follow-up are still scarce. The aim was to investigate long-term mortality and hospitalization and prognostic impact of gender after CRT...
  18. ncbi request reprint HeartWare left ventricular assist device thrombosis in aspirin non-responder
    Magnus Dalén
    Department of Molecular Medicine and Surgery, Department of Cardiothoracic Surgery and Anesthesiology, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden
    Asian Cardiovasc Thorac Ann 22:203-4. 2014
    ..There is a need for clinical trials determining optimal antiplatelet therapy in patients supported with left ventricular assist devices, and consensus regarding modification of antiplatelet therapy after device thrombosis. ..
  19. doi request reprint Change in blood pressure during hospitalisation for acute heart failure predicts mortality
    Per Svensson
    Department of Emergency Medicine, Karolinska University Hospital Solna, Stockholm, Sweden
    Scand Cardiovasc J 44:325-30. 2010
    ..The primary objective was to study the impact of the change in BP during a hospitalisation for acute HF on prognosis...
  20. ncbi request reprint Predicting survival in heart failure: validation of the MAGGIC heart failure risk score in 51,043 patients from the Swedish Heart Failure Registry
    Ulrik Sartipy
    Department of Cardiothoracic Surgery and Anesthesiology, Karolinska University Hospital, Stockholm, Sweden Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
    Eur J Heart Fail 16:173-9. 2014
    ..The aim of this study was to evaluate the performance of a recently developed risk score for mortality in heart failure by external validation in a national heart failure registry...
  21. pmc Sex differences in response to maximal exercise stress test in trained adolescents
    Asa Fomin
    Department of Cardiology, Karolinska Institutet, Karolinska University Hospital, N1 05, SE 17176, Stockholm, Sweden
    BMC Pediatr 12:127. 2012
    ..Sex comparisons between girls and boys in response to exercise in trained adolescents are missing and we investigated similarities and differences as a basis for clinical interpretation and guidance...
  22. ncbi request reprint Assessment of a University of California, Los Angeles 4-variable risk score for advanced heart failure
    Ulrik Sartipy
    Department of Cardiothoracic Surgery and Anesthesiology, Karolinska University Hospital, Stockholm, Sweden U S Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden U S
    J Am Heart Assoc 3:e000998. 2014
    ..However, the model has not been externally validated, and its suitability as a selection tool for heart transplantation (HT) and left ventricular assist device (LVAD) is unknown...
  23. ncbi request reprint Comparison of peak exercise oxygen consumption and the Heart Failure Survival Score for predicting prognosis in women versus men
    Philip Green
    Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA
    Am J Cardiol 99:399-403. 2007
    ..The HFSS was consistent between genders. In conclusion, peak VO2 and the HFSS are excellent parameters to predict survival in women with congestive heart failure. THE HFSS is more consistent than the peak VO2 between the genders...
  24. ncbi request reprint Predicting survival in ambulatory patients with severe heart failure on beta-blocker therapy
    Lars H Lund
    Department of Medicine, Columbia University, New York, New York, USA
    Am J Cardiol 92:1350-4. 2003
    ..The efficacy of these prognostic variables in patients receiving beta-blocker therapy was evaluated...